Sign up
Quantellect · Congress · Issuer Profile
NYSE: UNHUnitedHealth Group Incorporated
HealthcareMkt Cap $350.16BCongress ownership rank #8

UnitedHealth Group Incorporated Congressional Trading

According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 532 trades in UnitedHealth Group Incorporated (NYSE: UNH) since 2014, across 78 members, worth an estimated $13.7M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 264 buys against 268 sells, a modestly sell-led skew, with Democratic members responsible for 39% of the trades and Republican members 61%. The most recent disclosure shown was filed August 2026, and Rohit Khanna has filed the most UNH transactions among those shown, with 16. Other recent filers include Richard Dean Dr McCormick, Dan Newhouse, and Maria Elvira Salazar. One notable disclosed move was a purchase by Alan Armstrong on March 27, 2026, up 53.1% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the UnitedHealth Group Incorporated (UNH) stock overview and the complete trade table below.

Data updated

Trades
54
Politicians
17
Filings
32
Disclosed Vol
$1.3M
Buys
27
50%
Sells
27
50%

Price & congressional trade timeline

Party breakdown

UnitedHealth Group congressional trading activity

PoliticianPublishedTradedFiled AfterTypeSizeReturnOwner
Aug 14, 2026Jul 30, 202615 daysSELL
$1,001 - $15,000
-5.90%Self
Jul 17, 2026Jul 10, 20267 daysSELL
$1,001 - $15,000
-6.60%Spouse
Jul 9, 2026Jun 12, 202627 daysSELL
$1,001 - $15,000
-2.37%Self
Jul 9, 2026Jun 12, 202627 daysSELL
$1,001 - $15,000
-2.37%Self
Jul 7, 2026Jun 4, 202633 daysSELL
$1,001 - $15,000
+0.60%Self
Jul 13, 2026Jun 4, 202639 daysBUY
$1,001 - $15,000
+0.60%Joint
Jun 9, 2026May 15, 202625 daysBUY
$1,001 - $15,000
+0.70%Spouse
May 8, 2026Apr 22, 202616 daysBUY
$1,001 - $15,000
+12.18%Self
May 8, 2026Apr 22, 202616 daysBUY
$1,001 - $15,000
+12.18%Self
May 8, 2026Apr 14, 202624 daysBUY
$1,001 - $15,000
+26.23%Self
Go to

UnitedHealth Group (UNH) congressional trading FAQ

Can members of Congress legally trade UnitedHealth Group (UNH) stock?

Yes. Members of Congress are permitted to trade individual stocks, including UnitedHealth Group (UNH), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.

Are congressional UnitedHealth Group (UNH) trades public?

Yes. Every congressional trade in UnitedHealth Group (UNH) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.

How many times has Congress traded UnitedHealth Group (UNH)?

Members of Congress have disclosed 532 trades in UnitedHealth Group (UNH) worth $13.7M across 78 members, according to public STOCK Act filings.

Which members of Congress have traded UnitedHealth Group (UNH)?

Recent and active filers of UnitedHealth Group (UNH) disclosures include Rohit Khanna, Richard Dean Dr McCormick, Gilbert Cisneros. The full member-by-member trade list is on this page.

Do Democrats or Republicans trade UnitedHealth Group (UNH) more?

Across disclosed UnitedHealth Group (UNH) trades, 39% were by Democrats and 60% by Republicans, led by Republicans (60%).

What is the most recent congressional UnitedHealth Group (UNH) trade?

The most recent disclosed UnitedHealth Group (UNH) trade was a sale by Richard Dean Dr McCormick, filed Aug 13, 2026.

Browse all stocks Congress tradesCongressional trading overviewUnitedHealth Group (UNH) stock overview

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.